CDMO

A new era in Advanced Therapy Medicinal Products (ATMP) development and automation

Tetec CDMO has become part of the Octane Group of Companies, merging Tetec’s unrivalled ATMP expertise with Octane's leadership in advanced automated bioreactors. This synergy creates a powerhouse in personalized, complex cell therapies, delivering seamless technology transfer, innovative automation, and proven regulatory success. With decades of experience and industry-leading systems, we accelerate your therapy’s journey from concept to commercialization while maintaining the highest standards of quality and scalability. Discover how Octane CDMO redefines the future of advanced cell therapies.